Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-02-22 @ 10:23 AM
Study NCT ID:
NCT03325556
Status:
COMPLETED
Last Update Posted:
2021-06-21
First Post:
2017-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Dementia-related Psychosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Dementia | View |
| None | Dementia-related psychosis | View |
| None | Dementia associated with Parkinson's disease | View |
| None | Dementia with Lewy bodies | View |
| None | Alzheimer's disease | View |
| None | Behavioral variant frontotemporal dementia | View |
| None | Progressive supranuclear palsy | View |
| None | Corticobasal degeneration | View |
| None | Vascular dementia | View |
| None | Hallucinations | View |
| None | Delusions | View |
| None | Psychosis | View |